Market Overview

Benzinga's Top Upgrades, Downgrades For October 23, 2020

Share:

Upgrades

  • For Mattel Inc (NASDAQ: MAT), DA Davidson upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, Mattel showed an EPS of $0.95, compared to $0.26 from the year-ago quarter. The stock has a 52-week-high of 14.83 and a 52-week-low of 6.53. At the end of the last trading period, Mattel closed at $12.92.
  • For Spire Inc (NYSE: SR), Credit Suisse upgraded the previous rating of Neutral to the current rating Outperform. Spire earned $0.07 in the third quarter, compared to $0.07 in the year-ago quarter. The current stock performance of Spire shows a 52-week-high of 87.96 and a 52-week-low of 50.58. Moreover, at the end of the last trading period, the closing price was at $58.24.
  • According to Stephens & Co., the prior rating for Stewart Information Services Corp (NYSE: STC) was changed from Equal-Weight to Overweight. For the third quarter, Stewart Information Servs had an EPS of $2.21, compared to year-ago quarter EPS of $1.28. The current stock performance of Stewart Information Servs shows a 52-week-high of 49.48 and a 52-week-low of 20.26. Moreover, at the end of the last trading period, the closing price was at $42.10.
  • Susquehanna upgraded the previous rating for StoneCo Ltd (NASDAQ: STNE) from Neutral to Positive. In the second quarter, StoneCo showed an EPS of $0.10, compared to $0.16 from the year-ago quarter. The current stock performance of StoneCo shows a 52-week-high of 60.76 and a 52-week-low of 17.72. Moreover, at the end of the last trading period, the closing price was at $57.88.
  • Susquehanna upgraded the previous rating for PulteGroup Inc (NYSE: PHM) from Neutral to Positive. In the third quarter, PulteGroup showed an EPS of $1.34, compared to $1.01 from the year-ago quarter. The current stock performance of PulteGroup shows a 52-week-high of 49.7 and a 52-week-low of 17.12. Moreover, at the end of the last trading period, the closing price was at $42.65.
  • MKM Partners upgraded the previous rating for Motorola Solutions Inc (NYSE: MSI) from Neutral to Buy. In the second quarter, Motorola Solutions showed an EPS of $1.39, compared to $1.69 from the year-ago quarter. The current stock performance of Motorola Solutions shows a 52-week-high of 187.49 and a 52-week-low of 120.77. Moreover, at the end of the last trading period, the closing price was at $168.99.
  • Benchmark upgraded the previous rating for Seagate Technology PLC (NASDAQ: STX) from Hold to Buy. Seagate Technology earned $0.93 in the first quarter, compared to $1.03 in the year-ago quarter. The stock has a 52-week-high of 64.17 and a 52-week-low of 39.02. At the end of the last trading period, Seagate Technology closed at $51.79.
  • For TRI Pointe Group Inc (NYSE: TPH), B. Riley FBR upgraded the previous rating of Neutral to the current rating Buy. In the third quarter, TRI Pointe Group showed an EPS of $0.63, compared to $0.44 from the year-ago quarter. The stock has a 52-week-high of 19.59 and a 52-week-low of 5.89. At the end of the last trading period, TRI Pointe Group closed at $16.79.
  • JMP Securities upgraded the previous rating for Redwood Trust Inc (NYSE: RWT) from Market Perform to Market Outperform. In the second quarter, Redwood Trust showed an EPS of $1.00, compared to $0.39 from the year-ago quarter. At the moment, the stock has a 52-week-high of 18.01 and a 52-week-low of 2.14. Redwood Trust closed at $8.35 at the end of the last trading period.
  • RBC Capital upgraded the previous rating for PulteGroup Inc (NYSE: PHM) from Sector Perform to Outperform. In the third quarter, PulteGroup showed an EPS of $1.34, compared to $1.01 from the year-ago quarter. The current stock performance of PulteGroup shows a 52-week-high of 49.7 and a 52-week-low of 17.12. Moreover, at the end of the last trading period, the closing price was at $42.65.
  • According to RBC Capital, the prior rating for Whirlpool Corp (NYSE: WHR) was changed from Underperform to Sector Perform. For the third quarter, Whirlpool had an EPS of $6.91, compared to year-ago quarter EPS of $3.97. The current stock performance of Whirlpool shows a 52-week-high of 207.3 and a 52-week-low of 64.0. Moreover, at the end of the last trading period, the closing price was at $193.77.
  • According to Piper Sandler, the prior rating for EOG Resources Inc (NYSE: EOG) was changed from Neutral to Overweight. For the second quarter, EOG Resources had an EPS of $0.23, compared to year-ago quarter EPS of $1.31. The current stock performance of EOG Resources shows a 52-week-high of 89.54 and a 52-week-low of 27.0001. Moreover, at the end of the last trading period, the closing price was at $36.92.
  • Piper Sandler upgraded the previous rating for Pioneer Natural Resources Co (NYSE: PXD) from Neutral to Overweight. For the second quarter, Pioneer Natural Resources had an EPS of $0.32, compared to year-ago quarter EPS of $2.01. The stock has a 52-week-high of 159.01 and a 52-week-low of 48.62. At the end of the last trading period, Pioneer Natural Resources closed at $83.02.

 

Downgrades

  • For The Kroger Co (NYSE: KR), Evercore ISI Group downgraded the previous rating of Outperform to the current rating In-Line. For the second quarter, Kroger had an EPS of $0.73, compared to year-ago quarter EPS of $0.44. The current stock performance of Kroger shows a 52-week-high of 37.22 and a 52-week-low of 24.09. Moreover, at the end of the last trading period, the closing price was at $32.64.
  • Keefe, Bruyette & Woods downgraded the previous rating for Wintrust Financial Corp (NASDAQ: WTFC) from Outperform to Market Perform. Wintrust Financial earned $1.67 in the third quarter, compared to $1.69 in the year-ago quarter. At the moment, the stock has a 52-week-high of 71.95 and a 52-week-low of 22.0215. Wintrust Financial closed at $50.34 at the end of the last trading period.
  • JP Morgan downgraded the previous rating for TAL Education Group (NYSE: TAL) from Overweight to Neutral. In the second quarter, TAL Education showed an EPS of $0.08, compared to $0.02 from the year-ago quarter. The stock has a 52-week-high of 83.675 and a 52-week-low of 36.12. At the end of the last trading period, TAL Education closed at $66.30.
  • According to Jefferies, the prior rating for Navistar International Corp (NYSE: NAV) was changed from Buy to Hold. Navistar International earned $0.08 in the third quarter, compared to $1.47 in the year-ago quarter. The stock has a 52-week-high of 45.25 and a 52-week-low of 15.01. At the end of the last trading period, Navistar International closed at $43.12.
  • For Citrix Systems Inc (NASDAQ: CTXS), Morgan Stanley downgraded the previous rating of Overweight to the current rating Equal-Weight. Citrix Systems earned $1.38 in the third quarter, compared to $1.52 in the year-ago quarter. The current stock performance of Citrix Systems shows a 52-week-high of 173.56 and a 52-week-low of 100.31. Moreover, at the end of the last trading period, the closing price was at $126.65.

 

Initiations

  • With a current rating of Buy, Truist Securities initiated coverage on Pfizer Inc (NYSE: PFE). The price target seems to have been set at $42.00 for Pfizer. Pfizer earned $0.78 in the second quarter, compared to $0.80 in the year-ago quarter. At the moment, the stock has a 52-week-high of 40.97 and a 52-week-low of 27.88. Pfizer closed at $37.46 at the end of the last trading period.
  • Truist Securities initiated coverage on Merck & Co Inc (NYSE: MRK) with a Buy rating. The price target for Merck & Co is set to $96.00. In the second quarter, Merck & Co showed an EPS of $1.37, compared to $1.30 from the year-ago quarter. At the moment, the stock has a 52-week-high of 92.64 and a 52-week-low of 65.25. Merck & Co closed at $79.20 at the end of the last trading period.
  • Truist Securities initiated coverage on Eli Lilly and Co (NYSE: LLY) with a Buy rating. The price target for Eli Lilly is set to $180.00. Eli Lilly earned $1.89 in the second quarter, compared to $1.50 in the year-ago quarter. At the moment, the stock has a 52-week-high of 170.75 and a 52-week-low of 101.36. Eli Lilly closed at $141.59 at the end of the last trading period.
  • Truist Securities initiated coverage on Bristol-Myers Squibb Company (NYSE: BMY) with a Hold rating. The price target for Bristol-Myers Squibb is set to $65.00. Bristol-Myers Squibb earned $1.63 in the second quarter, compared to $1.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of 68.34 and a 52-week-low of 45.76. Bristol-Myers Squibb closed at $60.76 at the end of the last trading period.
  • With a current rating of Buy, Truist Securities initiated coverage on AbbVie Inc (NYSE: ABBV). The price target seems to have been set at $110.00 for AbbVie. AbbVie earned $2.34 in the second quarter, compared to $2.26 in the year-ago quarter. The current stock performance of AbbVie shows a 52-week-high of 101.28 and a 52-week-low of 62.55. Moreover, at the end of the last trading period, the closing price was at $84.30.
  • With a current rating of Buy, HC Wainwright & Co. initiated coverage on ClearSign Technologies Corp (NASDAQ: CLIR). The price target seems to have been set at $4.00 for ClearSign Technologies. ClearSign Technologies earned $0.05 in the second quarter, compared to $0.09 in the year-ago quarter. The stock has a 52-week-high of 4.11 and a 52-week-low of 0.35. At the end of the last trading period, ClearSign Technologies closed at $2.48.
  • RBC Capital initiated coverage on WAVE Life Sciences Ltd (NASDAQ: WVE) with a Sector Perform rating. The price target for WAVE Life Sciences is set to $13.00. In the second quarter, WAVE Life Sciences showed an EPS of $1.15, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of 39.98 and a 52-week-low of 6.61. WAVE Life Sciences closed at $8.31 at the end of the last trading period.
  • With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Stoke Therapeutics Inc (NASDAQ: STOK). The price target seems to have been set at $49.00 for Stoke Therapeutics. Stoke Therapeutics earned $0.39 in the second quarter, compared to $1.54 in the year-ago quarter. The current stock performance of Stoke Therapeutics shows a 52-week-high of 40.7 and a 52-week-low of 15.82. Moreover, at the end of the last trading period, the closing price was at $38.81.
  • JMP Securities initiated coverage on Shutterstock Inc (NYSE: SSTK) with a Market Outperform rating. The price target for Shutterstock is set to $72.00. For the second quarter, Shutterstock had an EPS of $0.62, compared to year-ago quarter EPS of $0.33. The stock has a 52-week-high of 62.58 and a 52-week-low of 28.76. At the end of the last trading period, Shutterstock closed at $60.33.
  • With a current rating of Outperform, Oppenheimer initiated coverage on Shake Shack Inc (NYSE: SHAK). The price target seems to have been set at $90.00 for Shake Shack. Shake Shack earned $0.45 in the second quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of 93.0355 and a 52-week-low of 30.01. Shake Shack closed at $72.56 at the end of the last trading period.
  • With a current rating of Overweight, Cantor Fitzgerald initiated coverage on Cassava Sciences Inc (NASDAQ: SAVA). The price target seems to have been set at $24.00 for Cassava Sciences. Cassava Sciences earned $0.05 in the second quarter, compared to $0.06 in the year-ago quarter. The stock has a 52-week-high of 12.68 and a 52-week-low of 1.05. At the end of the last trading period, Cassava Sciences closed at $8.83.
  • RBC Capital initiated coverage on uniQure NV (NASDAQ: QURE) with an Outperform rating. The price target for uniQure is set to $61.00. uniQure earned $0.96 in the second quarter, compared to $0.83 in the year-ago quarter. The current stock performance of uniQure shows a 52-week-high of 76.6869 and a 52-week-low of 34.38. Moreover, at the end of the last trading period, the closing price was at $41.26.
  • With a current rating of Buy, Guggenheim initiated coverage on Nevro Corp (NYSE: NVRO). The price target seems to have been set at $190.00 for Nevro. For the second quarter, Nevro had an EPS of $1.21, compared to year-ago quarter EPS of $0.91. The current stock performance of Nevro shows a 52-week-high of 166.29 and a 52-week-low of 65.05. Moreover, at the end of the last trading period, the closing price was at $162.39.
  • RBC Capital initiated coverage on MeiraGTx Holdings PLC (NASDAQ: MGTX) with an Outperform rating. The price target for MeiraGTx Hldgs is set to $27.00. MeiraGTx Hldgs earned $0.69 in the second quarter, compared to $0.63 in the year-ago quarter. The current stock performance of MeiraGTx Hldgs shows a 52-week-high of 22.32 and a 52-week-low of 8.82. Moreover, at the end of the last trading period, the closing price was at $13.09.
  • With a current rating of Buy, Stifel initiated coverage on Hycroft Mining Holding Corp (NASDAQ: HYMC). The price target seems to have been set at $15.00 for Hycroft Mining Holding. The current stock performance of Hycroft Mining Holding shows a 52-week-high of 16.1713 and a 52-week-low of 6.8. Moreover, at the end of the last trading period, the closing price was at $7.75.
  • Brookline Capital initiated coverage on electroCore Inc (NASDAQ: ECOR) with a Buy rating. The price target for electroCore is set to $5.00. In the second quarter, electroCore showed an EPS of $0.13, compared to $0.41 from the year-ago quarter. At the moment, the stock has a 52-week-high of 3.3 and a 52-week-low of 0.3201. electroCore closed at $1.57 at the end of the last trading period.
  • Brookline Capital initiated coverage on CTI BioPharma Corp (NASDAQ: CTIC) with a Buy rating. The price target for CTI BioPharma is set to $7.00. In the second quarter, CTI BioPharma showed an EPS of $0.19, compared to $0.19 from the year-ago quarter. The current stock performance of CTI BioPharma shows a 52-week-high of 3.68 and a 52-week-low of 0.62. Moreover, at the end of the last trading period, the closing price was at $3.34.
  • With a current rating of Sector Perform, RBC Capital initiated coverage on CRISPR Therapeutics AG (NASDAQ: CRSP). The price target seems to have been set at $110.00 for CRISPR Therapeutics. For the second quarter, CRISPR Therapeutics had an EPS of $1.30, compared to year-ago quarter EPS of $1.01. The current stock performance of CRISPR Therapeutics shows a 52-week-high of 111.9 and a 52-week-low of 32.3. Moreover, at the end of the last trading period, the closing price was at $90.16.
  • Wedbush initiated coverage on BigCommerce Holdings Inc (NASDAQ: BIGC) with a Neutral rating. The price target for BigCommerce Holdings is set to $90.00. Interestingly, in the second quarter, BigCommerce Holdings's EPS was $0.38. The current stock performance of BigCommerce Holdings shows a 52-week-high of 162.5 and a 52-week-low of 63.7716. Moreover, at the end of the last trading period, the closing price was at $89.95.
  • Guggenheim initiated coverage on Axonics Modulation Technologies Inc (NASDAQ: AXNX) with a Buy rating. The price target for Axonics Modulation Tech is set to $77.00. For the second quarter, Axonics Modulation Tech had an EPS of $0.54, compared to year-ago quarter EPS of $0.68. The stock has a 52-week-high of 52.1 and a 52-week-low of 15.25. At the end of the last trading period, Axonics Modulation Tech closed at $48.52.
  • Guggenheim initiated coverage on Axogen Inc (NASDAQ: AXGN) with a Buy rating. The price target for Axogen is set to $24.00. Axogen earned $0.15 in the second quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of 18.84 and a 52-week-low of 7.16. At the end of the last trading period, Axogen closed at $13.35.
  • With a current rating of Outperform, RBC Capital initiated coverage on Allogene Therapeutics Inc (NASDAQ: ALLO). The price target seems to have been set at $55.00 for Allogene Therapeutics. In the second quarter, Allogene Therapeutics showed an EPS of $0.53, compared to $0.41 from the year-ago quarter. The current stock performance of Allogene Therapeutics shows a 52-week-high of 55.0 and a 52-week-low of 17.43. Moreover, at the end of the last trading period, the closing price was at $35.34.
  • RBC Capital initiated coverage on HealthEquity Inc (NASDAQ: HQY) with an Outperform rating. The price target for HealthEquity is set to $67.00. In the second quarter, HealthEquity showed an EPS of $0.42, compared to $0.45 from the year-ago quarter. At the moment, the stock has a 52-week-high of 88.78 and a 52-week-low of 34.4. HealthEquity closed at $55.14 at the end of the last trading period.
 

Related Articles (ABBV + ALLO)

View Comments and Join the Discussion!

Posted-In: Initiations top upgradesPenny Stocks Upgrades Downgrades Initiation Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
HYMCBMO CapitalInitiates Coverage On
DEMorgan StanleyMaintains335.0
SBNYRaymond JamesMaintains138.0
CORTHC Wainwright & Co.Maintains32.0
CYBBFCitigroupDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com